MX2017004657A - Fracciones de avena con concentracion potenciada de avenantramidas y metodos de elaboracion. - Google Patents

Fracciones de avena con concentracion potenciada de avenantramidas y metodos de elaboracion.

Info

Publication number
MX2017004657A
MX2017004657A MX2017004657A MX2017004657A MX2017004657A MX 2017004657 A MX2017004657 A MX 2017004657A MX 2017004657 A MX2017004657 A MX 2017004657A MX 2017004657 A MX2017004657 A MX 2017004657A MX 2017004657 A MX2017004657 A MX 2017004657A
Authority
MX
Mexico
Prior art keywords
concentration
methods
enhanced
making
oat fractions
Prior art date
Application number
MX2017004657A
Other languages
English (en)
Inventor
O'shea Marianne
Chu Yifang
JOHNSON Jodee
Original Assignee
Quaker Oats Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quaker Oats Co filed Critical Quaker Oats Co
Publication of MX2017004657A publication Critical patent/MX2017004657A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/115—Cereal fibre products, e.g. bran, husk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/197—Treatment of whole grains not provided for in groups A23L7/117 - A23L7/196
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cereal-Derived Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Physics & Mathematics (AREA)
  • Electromagnetism (AREA)
  • Toxicology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)

Abstract

Modalidades ejemplares proporcionan fracciones de avena y métodos para producir las fracciones de avena, de la especie Avena sativa, que tiene una concentración de avenantramidas totales que es de aproximadamente 2 a aproximadamente 25% en peso, y hasta aproximadamente 30% en peso o más, superior a la concentración antes del tratamiento con energía infrarroja. La concentración superior se logra sin el tratamiento con enzimas o la exposición a agentes fúngicos para incrementar la concentración de avenantramidas totales. En cambio, la concentración potenciada de avenantramidas se logra a través de la exposición a energía infrarroja por un período seleccionado.
MX2017004657A 2014-10-07 2015-10-07 Fracciones de avena con concentracion potenciada de avenantramidas y metodos de elaboracion. MX2017004657A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/508,580 US10335383B2 (en) 2014-10-07 2014-10-07 Oat fractions with enhanced Avenanthramide concentration and methods of making
PCT/US2015/054424 WO2016057632A1 (en) 2014-10-07 2015-10-07 Oat fractions with enhanced avenanthramide concentration and methods of making

Publications (1)

Publication Number Publication Date
MX2017004657A true MX2017004657A (es) 2017-07-26

Family

ID=55631804

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017004657A MX2017004657A (es) 2014-10-07 2015-10-07 Fracciones de avena con concentracion potenciada de avenantramidas y metodos de elaboracion.

Country Status (5)

Country Link
US (2) US10335383B2 (es)
EP (1) EP3203843B1 (es)
CA (1) CA2963932C (es)
MX (1) MX2017004657A (es)
WO (1) WO2016057632A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010228083B2 (en) * 2009-03-27 2014-05-22 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food Method for increasing concentration of avenanthramides in oats
WO2020065089A2 (en) * 2018-09-28 2020-04-02 Lantmännen Functional Foods Ab A consumable product comprising malted dehulled oat

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010228083B2 (en) 2009-03-27 2014-05-22 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food Method for increasing concentration of avenanthramides in oats
US9011947B2 (en) * 2009-06-14 2015-04-21 The Quaker Oats Company Method of preparing highly dispersible whole grain flour with an increased avenanthramide content

Also Published As

Publication number Publication date
US20160095335A1 (en) 2016-04-07
EP3203843A4 (en) 2018-04-04
CA2963932C (en) 2021-05-04
WO2016057632A1 (en) 2016-04-14
US11260037B2 (en) 2022-03-01
US10335383B2 (en) 2019-07-02
EP3203843B1 (en) 2021-02-17
US20190262296A1 (en) 2019-08-29
EP3203843A1 (en) 2017-08-16
CA2963932A1 (en) 2016-04-14

Similar Documents

Publication Publication Date Title
MX2020009461A (es) Anticuerpos anti-proteína que contiene dominio de inmunologlubina rfig elacionado con el receptor de poliovirus (pvrig) y métodos de uso.
MX2021014709A (es) Composiciones para usarse en el incremento de los niveles de globulos rojos y el tratamiento de enfermedad de celulas falciformes.
NZ733055A (en) Anti-c10orf54 antibodies and uses thereof
MX2019003623A (es) Composiciones y metodos para el tratamiento de afecciones oftalmicas.
ZA201902141B (en) Acid-alpha glucosidase variants and uses thereof
MX2016017108A (es) Composiciones y metodos para el cuidado personal.
EA201692098A1 (ru) Биокерамические композиции и их применение для биомодулирования
NZ720769A (en) Anti-siglec-8 antibodies and methods of use thereof
AU356754S (en) Lid
PH12019500376A1 (en) Acid-alpha glucosidase variants and uses thereof
MX2020004419A (es) Polipeptidos fhbp meningococicos modificados.
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MY182924A (en) Enzyme compositions and uses thereof
MX2023010501A (es) Profarmacos de dantroleno y metodos de su uso.
MX2017006015A (es) Composiciones para usar en el tratamiento de cancer renal.
WO2015120372A3 (en) Compositions and methods to inhibit ezh2 for the treatment of cardiovascular diseases
MX2020002852A (es) Tratamiento mejorado de dermatitis atopica con tradipitant.
MX2017006019A (es) Apilimod para uso en el tratamiento de melanoma.
PH12016502530A1 (en) Pharmaceutical compositions comprising dgla and use of same
PH12017501022A1 (en) Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same
PH12016502311A1 (en) Omega-3 analogues
PH12019500479A1 (en) Compositions for treating dementia
MX2017004657A (es) Fracciones de avena con concentracion potenciada de avenantramidas y metodos de elaboracion.
PH12016501658A1 (en) Sialylated glycoprotein compositions and uses thereof
MX2018007468A (es) Composiciones de colageno 7 y metodos para usar las mismas.